Publication | Closed Access

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib**The investigators had full access to the data and complete control over the design, conduct analysis, interpretation, and description of the study. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or in writing the report. The views expressed are those of the investigators alone.

RheumatologyThrombosisConduct AnalysisCardiovascular DiseaseMedicineClinical EpidemiologyClinical TrialsInflammatory Rheumatic DiseasePharmacotherapyCardiovascular Thrombotic EventsPublic HealthPharmacologyAnticoagulantArthritis TrialsInflammatory Arthritis